Interestingly, five out of the six mutations led to a frameshift, consistent with the findings of the TCGA (88%, 38/43) and much higher than the initial GATA3 mutational analysis performed by Sanger sequencing in breast cancer (30%, 2/6) [21]. This evidence concerns the gene GATA3 and breast carcinoma.